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In the mouse theVo elements ofthe TCR-a/(3 are encoded in acomplex oftightly
linked genes on chromosome six (1-3) . Two major V/3 haplotypes have been found .
Most common strains carry the Vab haplotype, which encodes -20 V/3 elements
(4-8) . A few strains carry the Vaa haplotype, in which a large deletion has elimi-
nated 10 Vf gene elements (9) . In addition, the Voa haplotype carries a functional
gene for V017 (V,1117a) (10) . A V017 gene is present in the Vob haplotype (V,B17b),
but is inactive due to a mutation in the coding region that generates a termination
codon (11).
We recently reported (10) that TCR-a//3 that utilize V017a react with very high
frequency to the murineMHC H-2 class II product, IE . This reactivity is demon-
strated most dramatically in IE' mice, where during the establishment of self toler-
ance, V017a' T cells are virtually eliminated (12) . This phenomenon has provided
a useful tool to study the process of self-tolerance ; however, experiments have been
limited because only a few strains carry the Voa haplotype and these strains are of
diverse genetic backgrounds, making it difficult to distinguish H-2 and non-H-2 effects
on V017a expression .
We report here the characteristics ofVol7a expression in a set ofnew mouse strains
constructed to have the Voa haplotype associated with various H-2 haplotypes in
related C57 mice . The results not only confirm the association of the deletion of
V017a' T cells in IE' mice, but also establish a second H-2-encoded ligaud for
V017a' T cells mapping to theK end of the H-2k haplotype, and suggest that CD4'
Vi317a' T cells are differentially selected in mice of different H-2 types .
Materials and Methods
Mice.
￿
Mice were either bred in our own facility or purchased from the Jackson Labora-
tory, Bar Harbor, ME .
mAbs and Flow Cytometric Analyses.
￿
mAbs used to characterize purified peripheral T cells
are listed in Table 1 . For use in flow cytometric analyses, in some cases, purified antibodies
were labeled with FITC or biotin-w-hydroxysuccinimide by standard procedures . Biotinylated
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(Bio)' antibodies were detected with phycoerythrin-streptavidin (PEAv; Tago Inc., Burlin-
game, CA) as a secondary reagent. Unconjugated murine antibodies were detected with an
FITC-labeled goat anti-mouse Ig secondary reagent (Calbiochem-Behring Corp., SanDiego,
CA). All samples were analyzed with an Epics C flow cytometer.
V(3 andH-2 Typing ofMice.
￿
Approximately 10 drops of peripheral blood were obtained
from the tail artery of mice to be typed. RBC were removed with Gey's solution (20) and
T cellsenriched on nylon fibercolumns(21, 22). Aliquots ofcells were stainedwith anti-H-2
antibodies. Forestimating T cell V0 expression, cells were stained with FITC-anti-CD4 and
FITC-anti-CD8 (separately or in combination) and simultaneously with Bio-antiV/3 plus
PEAv to estimate V/3 usage. The sum of CD4' plus CD8` Tcells in thesepreparations varied
from 75% to 90%. In some experiments mice were killed and T cells from lymph node cell
suspensions were similarly prepared and stained. In this case the sum of CD4' and CD8'
T cells varied from 95%v to 100%.
TABLE I
mAbs Used in These Studies
Produced from the same fusion that yielded KJ23a. Typed on H-2 congenic
mice.
Results
Production ofNew Va° Strains.
￿
We produced F1 mice by crossing either C57BR(H-
2k) or C57L(H-2b) mice to any of a number of H-2 congenic mice on the C57BL/10
(1110) background. The F1 mice were crossed to produce F2 progeny. T cells from
these mice were typed for H-2 haplotype. Mice homozygous at H-2 were distin-
guished from heterozygous mice both with antibodies specific for the parental H-2
haplotypes and by the fact that individual T cells from heterozygous mice expressed
approximately one half the amount of each parental H-2 haplotype. The T cells
were also typed for V/3 haplotype, using KJ23a to detect V017a of the V(3a haplo-
type and KJ16 to detect V08.1/8.2 carried only by the VRb haplotype. Vob homozy-
gous mice were identified by the complete lack of V017a' T cells (10-12) and ahigh
level of Va8' T cells, similar to that seen in the original Vob homozygous parent
of the cross. Voa/Vob heterozygous mice were identified by the presence of both
V08' and V0177a' T cells. In the case of V08, the level of expression was ti50%
of that seen in the Vob homozygous parent of the cross, reflecting allelic exclusion
in the V(3 complex in individual T cells (23). Levels of V017a in the heterozygous
mice were similarly reduced by allelic exclusion and, in addition, in a number of
cases by the presence of a tolerizing MHC product, such as IE. However, residual
' Abbreviations used in this paper: Bio, biotinylated; PEAv, phycoerythrinstreptavidin.
mAb Relevant specificity Reference
MK-Q8 Db,q 10"
11-4.1 Kk 13
34-2-12 Dd 14
28-13-3 Kb 15
GK-1 .5 CD4 16
53.6 CD8 17
KJ23a V017a 10
KJ16 V/3 (8.1 + 8.2) 18, 19Va17a+ T cells were detectable in every case. The important Voa homozygous mice
were identified in every case by the complete absence of V08+ T cells and the pres-
ence of at least some V017a+ T cells, again even in the presence of a tolerizing
MHC molecule. In fact, with no exception, staining with these antiVS antibodies
placed the several hundred mice examined in these studies unequivocally into one
of these three categories.
Some of these points are illustrated in Fig. 1 for an experiment in which 29
(B10.A(5R) x C57L)F2 mice were typed. Using antibodies to Dd and Db to distin-
guishthe two H-2 types, homozygous mice ofboth types were detected. H-2 hetero-
zygous mice were also identified, reacting with both antibodies, but with cells ex-
pressing -501 7o of the level of each compared with homozygous mice. For each of
these three groups, mice homozygous for Vob contained ti16-19% V08.1/8.2+ T
cells, while this percentage dropped about half to 9-10°Jo in Vob/Voaheterozygous
mice and to 0% in homozygous Voa mice. In H-2b mice a reciprocal pattern of ex-
pression was seen for V017a with N5% in Voa homozygous mice, 2.5% in a
Vob/Voa heterozygous mouse, and 0% in Vob homozygous mice. Due to the pres-
ence of the IEb molecule, N80% of Vf17a+ T cells were deleted in H-2 heterozy-
gous mice and in those homozygous forthe H-2 type of B10.A(5R). In this experi-
ment one mouse was identified that was both homozygous for Voa and for the H-2
type of B10.A(5R), and two Vaa/H-2b homozygous mice were found. Similarresults
were obtained with mice from each of the other crosses.
Mice homozygous for Voa and for H-2 were used as founder stock to establish
a new Voa strain. These mice occurred approximately with the predicted 1 in 16
frequency so that often a founder pair was identified after typing 30-50 F2 mice.
In some cases a male and a female double-homozygous pair was not isolated, so
that one double-homozygous mouse was bred with a mouse homozygous at only
one of the loci. The double-homozygous mice identified among the F3 progeny with
afrequency of N50% were used to establish the strain. Once established, the strains
were maintained by breeders taken whenever possible from asingle litter. New breeders
also were selected for black coat color in order to select for the eventual loss of the
leaden and brown coat color genes of C57L and C57BR.
The resulting strains, while neither completely congenic nor inbred, differed at
H-2 andonly some of the genesthat distinguish the closely related C57BL, C57BR,
and C57L strains. To control partially for these differences, H-2kNoa and H-2b/Voa
KAPPLER ET AL.
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FIGURE 1.
￿
H-2 and VO typing of (B10.A(5R) x
C57L)F2 mice. T cells were prepared from the pe-
ripheral blood of 29 (B10.A(5R) x C57L)F2 mice
andtypedforH-2 andV/3as describedin Materials
and Methods and Results, staining with MK-Q8
(anti-Db), 34-2-12 (anti-Dd), KJ23a (antiVol7a),
and KJ16 (anti-V#8.1+8.2). H-2 data are shown as
the relative mean fluorescence intensitynormalized
to an average of 100 for T cells from the homozy-
gous mice. V/3 data areexpressed as the percent of
total CD4' plus CD8' cells that stained with each
of the antiVo antibodies. Each point represents a
determination made in an individual mouse.
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TABLE II
Origins of New V,(3° Mouse Strains
mice produced by the same strategy were compared with C57BRand C57L, respec-
tively, to see if mixing C57BL genes with those of C57BR or C57L mice altered
expression of V017a. In the case of H-2k, this also produced a strain that bred much
better than C57BR.
An additional Vaa strain was produced by backcrossing the SJL-derived Voa
complex to C57BL/10 mice, again typing progeny with anti-H-2h and antiV(3 an-
tibodies. At the Ft; generation males and females from the same litter
to produce an N6 H-26/Voa homozygous strain.
The origins of the nine new Voa strains are summarized in Table
Deletion of Vol7a' Tcells in IE` Voa Mice.
￿
The new Voa strains were compared
with existing Voa strains for the expression of V017a in CD4' and CD8+ T cells.
Purified lymph node T cells were stained simultaneously with either FITC-labeled
anti-CD4 or anti-CD8 and Bio-antiVO17a plus PEAv. Sample fluorescence histo-
grams are shown in Fig. 2 for some of the strains. The summarized results of all
were mated
FIGURE 2 .
￿
Deletion of V017a' CD4* and CD8' T cells in IE'
mice. Nylon fiber-purified lymph node T cells from B10.QpaR,
B10.A(5R)0L, and C57BR mice were stained with either FITC-
anti-CD4 or FITC-anti-CD8 and with Bio-antiVR17a plus PEAv.
Histograms show the red fluorescence ofthe green fluorescent cells.
Percentages refer to the percentage of total green fluorescence cells
staining red in the shaded area.
V/3" strain Type K
H-2
A E D Derived from:
B10.Q3BR q 9 9 - 9 (B10.Q x C57BR)F2/F3
B10.S(7R)01, t2 s s - d (B10.S[7R] x C57L)F2
141001, b b b - b B10.HTT x C57L)F2
B10.#J(N6) b b b - b (C57BL/10 x [C57BL/10 x SJL]F1)F6
B10.A(4R)01, h4 k k - d (B10.A[4R] x C57L)F2
B10.D201. d d d d d (B10.D2 x C57L)F2/F3
B10.A(5R)01, i5 b b b d (B10.A[5R] x C57L)F2/F3
B10.HTT01, t3 s s s d (B10.HTT x C57L)F2/F:;
B10.BROBR k k k k k (B10.BR x C57BR)F2' Average ± SEM of determinations made in three or more mice .
Total T cells equals the sum of CD4' plus CD8' T cells .
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TABLE III
14817a Expression in Vfl' Mice
the strains are listed in Table III and as the average percent ofeither CD4', CD8+,
or total T cells expressing V017a .
As expected, V017a+ T cells were depressed in all of the new Vaa strains bearing
an IE molecule. That this low expression was due to tolerance to IE was confirmed
by the dominant low expression in the Vaa homozygous/IE heterozygous F2 and
F3 mice examined in the course of isolating these strains (Fig . 3) . In each case the
deletion ofV017a+ T cells was as striking in IE' x IE- heterozygous mice as in
IE' homozygous mice .
In ourprevious experiments it was difficult to comparethe efficiencies of different
IE molecules in this deletion because we had to use F1 mice in which either the IE
or the V017a structural gene or both were heterozygous (12) . However, in these new
FIGURE 3 .
￿
Elimination of V017a'T cells is dominant in IE'
x IE - heterozygous mice . Theextent ofV017aexpression is
shown for the Vaa homozygous F2 and F3 progeny of the
crosses between IE' and IE- mice shown in Table II . The first
panel contains the data forIE- , H-2 homozygous progeny; the
second panel, for IE', H-2 heterozygous mice ; and the third
panel, for IE', H-2 homozygous mice . In two cases the het-
erozygous mice express the IEb molecule as a result of com-
plementation between Eat from the IE-expressing parent and
E/86 from the non-IE-expressing C57L (H-26) parent . Each
point represents a determination made in a different mouse .
The data are expressed as the percent of total CD4' plus
CD8' cells that expressed V017a .
VRa strain Type K
H-2
A E D
T
Percent of CD4'
T cells
cells expressing VO17a'
Percent of CD8'
T cells
Percent of total
T cellst
SWR q q q - q 18 .5 ± 0.6 4.6 ± 0.4 15 .1 t 0.6
B10.Q -8BR q q q - q 13 .2 t 0.5 3.7 t 0.2 9 .9 ± 0.4
SJL s s s - s 10 .9 ± 0.2 7 .1 t 0.3 9.8 t 0.2
B10.S(7R)OL t2 s s - d 5.0 t 0.5 3.6 t 0.1 4.3 ± 0.3
C57L b b b - 6 2.8±0.2 6 .3 ± 0.7 4.2±0.4
B10SL b b b - 6 3.1 f 0.2 6 .3 ± 0.3 4.1 f 0.4
B10.RJ(N6) b b b - b 3.4 f 0.3 7 .3 t 0.2 4.9 t 0.2
B10.A(4R)OL h4 k k - b 1 .7 ± 0 .1 0.9 ± 0.0 1 .3 ± 0.0
B10.D20L d d d d d 1 .3 t 0 .2 2 .5 t 0.3 1 .8 ± 0.2
BIO.A(5R)OL i5 b b b d 0.5 ± 0 .2 2 .2 ± 0.5 1 .1 ± 0.3
B10.HTTOL t3 s s s d 0.6±0 .1 1 .1 ± 0.3 0.8±0.2
BIO.BROBR k k k k k 0.2 ± 0 .1 0.3 t 0.2 0.3 t 0.1
C57BR k k k k k 0.1 t 0.1 0.1 ± 0.0 0.1 t 0 .01538
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Vaa strains, where both the IE and V017a genes are homozygous, we could clearly
see that not all IE molecules delete V017a+ T cells equally well (Table III, Fig. 4).
Complementing our previous finding (10, 24) that V017a+ T cell hybridomas
responded with lowest frequency to IEd, the B10.D2RL mice bearing IEd had the
greatest number of VS17a+ T cells surviving tolerance. This was followed by
B10.A(5R)0L(IEb), B10.HTTSL (IE'), and finally, B10.BROBR(IEk). In the last case
the interpretation is clouded somewhat by a second deleting gene mapping to the
K end of H-2k (see below). It is worth noting that combination of the B10 back-
ground genes with those from C57BR to construct B10.BRQBR strain did not
significantly alter the virtually complete deletion of V017a+ T cells.
In each of the IE+ strains, deletion of V017a+ T cells was evident among both
the CD4+ and CD8+ T cells, although deletion among CD4+ T cells appeared more
efficient (Table III, Fig. 2). For many CD4+/Vo17a+ T cell hybridomas, loss of or
blockage of the CD4+ molecule results in loss of IE reactivity (data not shown).
Thus, the deletion of CD8+/V017a+ T cells by IE suggests that deletion occurred
at a stage of development when these cells bore CD4 and, therefore, reinforces the
accumulating evidence for a CD4+/CD8+ intermediate in T cell development with
at least some self-tolerance induction at this stage (25, 26). The skewing of V017a+
T cell deletion toward CD4+ T cells may suggest that, in addition, some of the de-
letion occurs afterthe cells have become CD4or CD8 single-positive T cells, or could
simply indicate that the small proportion of V017a+ T cells that are not IE reactive
may be enriched in Tcells selected by class I ligands in thethymus and are destined
to become CD8+ .
Differences in Expression of V017a in IE- V(oa Mice.
￿
Some of the most noteworthy
results on Va17a expression were obtained in the new IE- Voa strains. Forexample,
direct evidence that non-H-2 genes affect the levels of Va17a+ T cells came from
comparing the two Voa H-2v mice. There were considerably more V017a+ T cells
in SWR mice than in B10.QfiBR mice, especially among CD4+ T cells. V017a ex-
pression was also considerably higher in SJLthan in B10.S(7R), although thediffer-
ence at H-2D as well as in the non-H-2 background genes may play a role here.
On the other hand, V017a expression did not differ significantly among the three
H-26 mice carrying different mixes of the background genes from C57L and 1310
mice, again pointing out the relatedness of the C57 mice.
One surprising result was the low expression of V017a+ T cells (1.3%) in IE-
B10.A(4R)aL mice (Table III). Comparison of these mice to any of the H-26 Vaa
mice suggests that a second H-2 gene mapping to the K end of H-2k also causes
significant deletion of V017a+ T cells. Alternatively, it is possible that the B10.A(4R)
H-2 products simply poorly select V017a+ T cells during T cell development. Evi-
FIGURE 4.
￿
H-2 and V/3 typing ofVRa homozy-
gous (B10.A(4R) x C57L)F2 mice. Eight VRa
homozygous mice were analyzed for H-2 and
V/3 as in Fig. 1, except that 28-13-3 (anti-Kb) and
11-4.1 (anti-Kk) were used for the H-2 typing.
(4RxC57L )Fz Relative Level of % T cells Expressing
H-2 Kb Kk \017a V08.1+8.2
V'd K AE D 100 50 50 100 3 2 1 1 2 3
bb-b
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a/a
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dente that this low expression is in fact due to deletion was seen during the analysis
of the F2 mice used to construct this strain (Fig. 4). Low expression of Vol7a was
seen both among the mice homozygous and heterozygous for the H-2 type of
B10.A(4R), reflecting thedominance expected ofdeletion due to self-tolerance. This
non-IE-deleting elements perhaps explains why in H-2k mice, which carry both this
element and the IEk molecule, the deletion of V017a' T cells is virtually complete.
While the deleting K end gene product could be either IA' or Kk, two observa-
tions favor Kk. First, although, as with IE, this deleting element deletes both CD4+
and CD8+ T cells in B10.A(4R)gi, mice, in this case the effect is more dramatic on
CD8+ than CD4+ T cells. Second, in our studies of the reactivity of V017a' T cell
hybridomas (10, 24), we have found only occasional responsiveness to IAk. At
present, we are unable to study most cases of class I recognition in T cell hybrid-
omas because the fusion partner, BW5147, supports CD4, but not CD8, expression
in its hybrids (27). Therefore, it is likely in these hybridoma studies that a CD4-
dependent reactivity to IA' would have been found were it to exist, but a CD8-
dependent response against Kk would have been missed.
With the exception of the B10.A(4R)fli, strain, expression of Va17a among CD8+
T cells varied only by a factor of about two (3 .6-7.3%). On the other hand there
was a much greater variation among CD4+ T cells, with a low of 2.8% in C57L
mice and a high of 18.5% in SWR. The high expression in B10.Q8BR (13.2%) vs.
low expression in the H-26 mice (2.8-3 .4%) established that much of this difference
was due to H-2. This phenomenon could reflect another gene deleting V017a' T
cells in the H-26 haplotype specific for CD4+ T cells; however, in this case, prelimi-
nary results have shown that high expression is dominant in (H-2q x H-26)F, mice
(Blackman, M., P. Marrack, andJ. Kappler, manuscript in preparation) favoring
the view that in the thymus, IAq is a much better selector of V017a' T cells than
is IAb. We are currently testing this idea in the appropriate chimeric mice.
Discussion
Mice carrying the Voa haplotype should be useful in T cell repertoire studies for
two reasons. First, they carry a functional structural gene for V017 (10, 11). Since
receptorsutilizingVol7a have theunusualproperty of reacting with high frequency
to B cell-presented IE molecules (10, 12, 28), Voa mice can be used to study the
phenomenon of self-tolerance to class II MHC ligands. A possible class I ligand
for V017a' T cells in H-2k may make the B10.A(4R)OL strain useful in studying
tolerance induction to class I MHC ligands. In addition, the dramatic difference
in CD4+ V017a' T cells between H-2q and H-26 suggests that IAq selects V017a'
better than IAb, perhaps offering a system in which the process of thymic positive
selection can be studied.
A second feature of the Voa haplotype is the remarkable deletion in the middle
of the complex of about half of the Vii elements (9). Although one might suppose
that this loss of receptor elements would be detrimental because it would limit the
diversity of the a,(3 receptor repertoire, the deletion has apparently been tolerated
evolutionarily for some time (29). The immunological consequences of this deletion
have not been extensively explored. We have suggested that this deletion and other
genetic mechanisms that limit the expression of particular Vo elements in different
mice may play a role in the mouse population at large in balancing the advantage1540
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of a large T cell repertoire against the potential involvement of these Vß elements
in autoimmune reactions (11, 12, 19, 30). The development of a set of Vßa mice of
similar background and carrying different IE + and IE- H-2 haplotypes should pro-
vide a useful tool to study this question.
Summary
A set of new mouse strains were produced that carry the Vßa haplotype of the
TCR-a/ß and any of a number of different H-2 haplotypes on backgrounds derived
from related C57BL, C57L, and C57BR mice. Study of Vß17a expression in these
mice confirms the association between the presence of IE and the deletion of Vß17a+
T cells. A second H-2 gene causing deletion of Vß17a+ T cells was mapped in these
mice to the K end of H-2k, and H-2 influences on the level of selection of CD4*
Vß17a+ T cells were indicated.
We thankJanice White, Terri Wade, and Rhonda Richards for their excellent technical support.
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